AKEBIA THERAPEUTICS INC.
AKEBIA THERAPEUTICS INC.
- USD (-)
- 15 min Ritardato - Azioni NASDAQ
Apertura: -
Variazione: -
Volumi: -
Minimo: -
Massimi: -
Distanza Mas/Min: -
Tipologia: Azioni
Ticker: AKBA
ISIN:

Akebia Therapeutics to Present at the 2019 Cantor Global Healthcare Conference

  • 25

Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease, today announced that John P. Butler, President and Chief Executive Officer of Akebia, will present at the 2019 Cantor Global Healthcare Conference at 8:55 a.m. ET on Thursday, October 3, 2019 in New York City.

A live audio webcast and replay of the presentation will be available on the Company’s website at www.akebia.com.

About Akebia Therapeutics

Akebia Therapeutics, Inc. is a fully integrated biopharmaceutical company focused on the development and commercialization of therapeutics for people living with kidney disease. The company was founded in 2007 and is headquartered in Cambridge, Massachusetts. For more information, please visit our website at www.akebia.com, which does not form a part of this release.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190924005613/en/

Business Wire
Business Wire
Business Wire, filiale del gruppo Berkshire Hathaway dal 2006, è il leader mondiale nella distribuzione di comunicati stampa e comunicazione normativa e aziendale. I professionisti della comunicazione e del marketing si affidano a Business Wire per la distribuzione integrale e simultanea dei loro comunicati, foto e video alle agenzie stampa, sistemi d’informazione professionale, siti internet, media, giornalisti, blogger, analisti e investitori di tutto il mondo.